Showing results (491-500 of 1,327) with videos related to

Sort By:
Pageof 133
Human Immunology|March 1, 1989
Mitogen-induced human IgG subclass expression. II. IgG1 and IgG3 subclasses are preferentially stimulated by a combination of Staphylococcus aureus Cowan I and pokeweed mitogenA W Butch, K A Macke, M G Scott, et al.
Experimental Dermatology|June 12, 2026
Vagus Nerve Stimulation Reduces Cutaneous Inflammation and Proinflammatory Cytokines in Murine Models of Psoriasis and Atopic DermatitisWilliam J Nahm, Ki-Joong Kim, Eui Namgung, et al.
Journal of Hazardous Materials|February 19, 2026
Dual-function of nitrogen removal and autoinducer-2 quorum quenching improves MBR performance in treating TMAH-containing wastewaterHyunjung Kim, Seung-Hun Baek, Gyeongho Choi, et al.
Journal of Clinical Microbiology|September 1, 1989
New fluorescence assay for the quantitation of fungiT Coleman, J V Madassery, G S Kobayashi, et al.
Immunology Letters|February 1, 1991
Cytokine production by T helper cell subpopulations during prolonged in vitro stimulationA W Butch, J Pesando, A D Levine, et al.
Peerj|November 30, 2016
Ficolin-2 inhibitors are present in sera after prolonged storage at -80 °CKimball Aaron Geno, Richard E Kennedy, Patricia Sawyer, et al.
Infection and Immunity|August 1, 1995
Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharideM H Nahm, K H Kim, P Anderson, et al.
Vaccine|June 22, 2011
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7ADavid Cooper, Xinhong Yu, Mohinder Sidhu, et al.
Journal of Clinical Laboratory Analysis|October 5, 2021
Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19Anna Lee, Chung Hyun Nahm, Jin-Soo Lee, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 1, 1993
A trial of individual dose intensity and relative performance factors in tegafur maintenance chemotherapy for head and neck cancerS Sawaki, H Watanabe, T Shin, et al.
Pageof 133